Skip to main content
. 2011 May 1;5(3):681–686. doi: 10.1177/193229681100500322

Table 1.

Pharmacokinetic and Pharmacodynamic Summary Measures after SC Injection of Regular Human Insulin (RHI), Insulin Lispro (LIS), and Ultra-Fast Insulin (UFI) in 18 Patients with Type 1 Diabetes Immediately Prior to a Standardized Mixed Meal (Mean ± SD)a

Variables RHI LIS UFI p valuesb
Pharmacokinetic
Baseline insulinemia (mU/liter) (only human insulin measured) 19.0 ± 14.2 21.4 ± 16.3 19.4 ± 19.2 RHI vs UFI .385 LIS vs UFI .080 RHI vs LIS .348
Early tCmax (min) 38.4 ± 19.5 25.4 ± 7.6 13.1 ± 5.2 <.001 .001 <.001
tCmax (min) 131.7 ± 49.5 65.6 ± 34.5 28.4 ± 17.4 <.001 .001 <.001
Late tCmax (min) 268.3 ± 54.3 147.5 ± 51.7 135.2 ± 45.7 <.001 .391 <.001
Cmax (μU/ml) 32.8 ± 20.3 57.5 ± 20.9 55.5 ± 24.8 .135 NA NA
AUC 0–180 (mU·min/liter) 3854 ± 2551 5850 ± 2106 5627 ± 2322 <.001 NA NA
AUC 0–300 (mU·min/liter) 5905 ± 3274 6876 ± 2619 6749 ± 2740 .068 NA NA
AUC 180–300 (mU·min/liter) 2051 ± 1169 1026 ± 960 1123 ± 727 .003 NA NA
Pharmacodynamic
Baseline BG (mg/dl) 124 ± 5 127 ± 6 123 ± 5 RHI vs UFI .444 LIS vs UFI .046 RHI vs LIS .211
Baseline GIR (mg·min/kg) 1.1 ± 1.3 0.7 ± 1.1 1.0 ± 1.1 .784 .507 .350
tBGmax (min) 83 ± 43 125 ± 146 181 ± 171 .014 .153 .274
Glucosemax (mg/dl) 191 ± 46 178 ± 46 174 ± 44 .262 .555 .090
Glucosemax 0–180 (mg/dl) 191 ± 46 170 ± 42 157 ± 30 .002 .668 .008
Glucosemax–min 0–180 (mg/dl) 91 ± 33 89 ± 18 70 ± 17 .007 .011 .858
AUCGlucose 0–180 (g·min/dl) 28.4 ± 7.6 22.4 ± 7.3 21.8 ± 5.8 <.001 .681 <.001
AUCGlucose 0–300 (g·min/dl) 43.3 ± 13.0 36.8 ± 13.0 36.3 ± 10.3 .057 .591 .016
AUCGlucose 181–300 (g·min/dl) 14.7 ± 5.7 14.2 ± 6.0 14.4 ± 5.1 .989 .524 .524
Amount glucose infused0–300 (g) 28 ± 100 40 ± 58 24 ± 89 .863 .470 .582
Duration BG80–140 no GIR 0–180 (min) 74 ± 60 81 ± 45 100 ± 58 .131 .250 .711
Duration BG80–140 no GIR 0–300 (min) 137 ± 85 136 ± 91 167 ± 92 .284 .266 .965
Duration of glucose infusion to prevent hypoglycemia (hour) 1.0 ± 1.2 0.8 ± 1.4 0.5 ± 0.8 .076 .330 .411
a

BG, blood glucose; GIR, glucose infusion rate;

b

NA, not applicable; bold font, significant differences.